Tonix Pharmaceuticals Holding Corp. (TNXP)

TNXP Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	10	10	22	157	106	2
Market Cap Growth	-88.00%	-57.15%	-85.74%	48.77%	5634.83%	-41.02%
Enterprise Value	13	-6	-97	-20	30	-9
PE Ratio	-	-0.08	-0.19	-1.70	-2.03	-0.06
PS Ratio	0.95	1.24	-	-	-	-
PB Ratio	0.09	0.09	0.11	0.72	1.21	0.20
P/FCF Ratio	-0.05	-0.09	-0.15	-1.42	-1.85	-0.07
P/OCF Ratio	-0.05	-0.09	-0.23	-2.08	-2.18	-0.07
EV/Sales Ratio	1.22	-0.71	-	-	-	-
EV/EBITDA Ratio	-0.08	0.05	0.89	0.22	-0.59	0.32
EV/EBIT Ratio	-0.07	0.05	0.88	0.22	-0.59	0.32
EV/FCF Ratio	-0.08	0.05	0.66	0.18	-0.52	0.34
Debt / Equity Ratio	0.09	0.09	0.00	0.00	0.01	0.04
Debt / EBITDA Ratio	-0.10	-0.09	-0.01	-0.01	-0.03	-0.01
Debt / FCF Ratio	-0.11	-0.09	-0.01	-0.01	-0.02	-0.01
Quick Ratio	0.34	1.32	6.61	8.23	7.87	2.21
Current Ratio	1.47	2.53	7.19	8.71	8.96	2.72
Asset Turnover	0.07	0.05	0	0	0	0
Return on Equity (ROE)	-83.00%	-87.70%	-53.60%	-47.40%	-88.80%	-249.20%
Return on Assets (ROA)	-67.00%	-73.80%	-48.30%	-44.60%	-80.90%	-201.00%
Return on Capital (ROIC)	-89.72%	-102.64%	-53.90%	-42.02%	-56.78%	-294.92%
Earnings Yield	-1008.31%	-1213.76%	-521.13%	-58.69%	-49.36%	-1687.00%
FCF Yield	-919.13%	-1133.03%	-651.87%	-70.51%	-54.05%	-1448.70%
Buyback Yield / Dilution	-687.64%	-191.70%	-220.61%	-285.23%	-5788.45%	-1294.44%
Total Shareholder Return	-687.64%	-191.70%	-220.61%	-285.23%	-5788.45%	-1294.44%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).